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Extensive  investigations  of  the  immunological response  to  streptococcal 
infection in man have been conducted to obtain information necessary to define 
streptococcal immunity and explain the pathogenesis of streptococcal infection, 
rheumatic fever, and glomerulonephritis.  Most of this work has been concerned 
with the host response to soluble enzymes and toxins of Group A streptococci 
(1, 2). Studies of the host response  to streptococcal cellular components have 
been limited because of the difficulty in  obtaining purified preparations  of 
these constituents (1). Recently cell wall (3, 4) and cell membrane (5) antigens 
of defined chemical and immunological specificity have been obtained. A cell 
wall polysaccharide fraction described in the preceding paper (6) was u~ 
in the present investigation as hemagglutination antigen to measure antibody 
to  Group  A  carbohydrate in  human  sera.  Experiments demonstrating the 
specificity of this serologic reaction and data describing the antibody response 
to streptococcal A polysaccharide in man are presented in this report. 
Since Lancefield described the C carbohydrate antigen of hemolytic strep- 
tococci  (7),  a  number  of  investigators  have  reported  finding precipitating 
antibody to A polysaccharide  in sera from normal persons, patients convalescent 
from streptococcal infection, and patients with rheumatoid arthritis, rheumatic 
fever, and glomerulonephritis (8-18).  In all  but two of these investigations, 
crude acid extracts of Group A streptococci were used as antigen and it is likely 
that  the precipitating antibody detected was  a  composite,  representative of 
multiple streptococcal cellular  antigens. Antibody precipitated by purified A 
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carbohydrate  was  found by Wilson and  Wiley in  the serum of a  patient  with 
streptococcal parotitis,  otitis,  and  septicemia  (9).  Halbert  described  immuno- 
diffusion reactions with human gamin a globulin and Streptomyces albus enzyme- 
prepared  A  polysaccharide  and  an  A  polysaccharide-protein  complex  (8).  In 
these studies, A  carbohydrate  antibody was not quantified nor were surveys of 
sera from different sources reported. 
Materials and Methods 
Polysaceharide Antigens.--Ethanol  and acetone-precipitated fractions of A polysaceharide 
were prepared  from diisopropyl fluorophosphate  (DFP)-treated  Streptomyces albus enzyme 
lysates of streptococcal cell walls as described in the preceding paper (6). Similar polysaccharide 
fractions were precipitated from lysates obtained with S. albus enzyme that was not treated 
with DFP.  Ethanol and  acetone fractions of A-variant polysaccharide  (19)  were isolated 
from lysates of cell walls of the T27A strain of streptococci according to the methods employed 
for A polysaceharide. Group A carbohydrate was also obtained from cell walls by extraction 
with formamide and purified with ion exchange resins (20).  Specific enzymatic hydrolysis of 
preparations of A polysaceharide with A enzyme, which selectively destroys A serologic ac- 
tivity, was performed at pH 6, r/2 0.2, at 25 ° and 37 ° C for 20 to 24 hours as described by 
MeCarty (21). Dr. 1VL McCarty generously provided the A enzyme. 
Column Ckromatograpky.--Chromatography  of polysaccharide  preparations on CM cellu- 
lose was performed according to Peterson and Sober  (22).  Columns  0.9 x 25 cm were used. 
Gradient elution was performed with phosphate buffer, pH 6.4,  1"/2 0.01; the ionic strength 
was gradually increased to 0.5 with NaC1. 
Preparation of Serum Specimens.--Hyperimmune rabbit sera containing antibody to A and 
A-variant polysaccharides were prepared according to methods  described  by McCarty  and 
Lancefield (19).  Human serum specimens were collected in the usual manner and stored at 
-20°C, or at refrigerator temperature. All sera used in hemagglutination tests were centrifuged 
and  passed  through a  Millipore filter (porosity 0.45/z)  for clarification and  inactivated by 
heating to 60°C for 15 minutes. They were then absorbed with human O erythrocytes by mix- 
ing 1 volume of serum with 1 volume of packed erythrocytes (RBC).  The  suspension  was 
kept at room temperature for 10 minutes with occasional mixing and then centrifuged at 2500 
P.r~ for 20 minutes at 2°C. The serum was carefully removed from the cells and stored at -- 20  ° 
or at 4°C. All serum dilutions were made with buffered saline, pH 7.2 (23) containing 1 per cent 
inactivated normal rabbit serum (NRS) that had been absorbed with human O RBC. 
Preparation of Reagents for Hemagglutinati~n and Hemagglutination Inhibition.- 
Human 0  erythro~ytes: Several type O donors were used. Cells from one  donor  produced 
more compact, clear-cut agglutination of RBC; therefore, cells from this donor were almost 
always used for comparing various sera or antigens. RBC were collected in ACD (24) solution 
and centrifuged at 2000 ~  at 2°C  (all centrifugations were performed at this  temperature) 
for 30 minutes. The supernatant  fluid and the huffy coat were removed and the RBC  resus- 
pended in ACD solution and centrifuged 20 minutes. This was repeated twice and  the  last 
centrifugation was run for 30 minutes to measure the packed RBC volume. RBC were stored 
as a 50 per cent suspension  in ACD solution of 2°C for no longer than 4 days. 
To prepare a  2.5 per cent suspension of RBC for treatment with tannic acid,  1 ml of 50 
per cent RBC was added to 20 ml of pH 7.2 buffer, mixed and centrifuged at 1500 RPM for 10 
minutes. The supernatant fluid was removed and the RBC resuspended in 19.5 ml of pH 7.2 
buffer. 
Preparation of Tanned RBC.--A 1 : 100 stock solution of reagent grade tannic acid was made 
in 0.85 per cent saline weekly and kept at 2°C. Each day, a  1:20,000 solution of tannic acid WILLARD  C.  SC~,rrDT  AND  DOROTHY J'.  MOORE  795 
in pH 7.2 buffer was prepared. Then 2 volumes of 2.5 per cent suspension of RBC were mixed 
with 1 volume of 1:20,000 tannic acid and 1 volume of pH 7.2 buffer and incubated at 37°C for 
10 minutes. The suspension was centrifuged at 1500 ~M for 10 minutes and  the supemate 
removed. The RBC were dispersed in the same volume of pH 7.2 buffer and  centrifugation 
repeated. The RBC were  then added  to  sufficient 0.85  per cent saline to  make a  2.5 per 
cent suspension. 
Sensitization of Tanne~ RBC.--One volume of 2.5 per cent tanned RBC was mixed with 0.9 
to 0.4 volume of pH 6.4 buffered saline (23) and 0.1 to 0.6 volume of antigen in distilled water 
or pH 6.4 buffered saline. The suspension was incubated at 37"C for 30 minutes with occasional 
mixing; it was then centrifuged at 1500 m,M for 10 minutes and the supernate removed. To 
wash the sensitized RBC, they were resnspended in pH 7.2 buffer containing 2 per cent heat- 
inactivated bovine serum albumin (BSA) to a final concentration of RBC of 1.25 per cent and 
centrifuged at 1500 xp~t for 10 minutes. This was repeated once; then the RBC were added 
to pH 7.2 buffer containing 2 per cent BSA to make a  2.5 per cent suspension of sensitized 
RBC. An unsensitized 2.5 per cent RBC suspension was prepared in the same manner without 
added antigen. Sensitized RBC were prepared fresh daily. Because agglutination of RBC was 
less compact in the presence of merthiolate, it was not put in any of the reagents except the 
original undiluted serum specimen to be tested. Bacterial contamination also interfered with 
hemagglutination so that all reagents were autoclaved or sterilized by filtration, and sterile 
technique was used in all procedures from the drawing of blood through the preparation of 
sensitized cells. 
Hamagglutination.--Dilutions  of sera to be tested were pipetted in 0.5 ml amounts into 
carefully cleaned 10 x 75 mm test tubes and 0.05 ml of sensitized RBC suspension was added. 
The tubes were shaken to mix sensitized cells and serum thoroughly and then kept at  4°C 
overnight. The reactions were graded from 0  to 4+  according to criteria slightly modified 
from those described by Stavitsky (23). Serum controls consisted of one or more of the lower 
serum dilutions reacted with non-sensitized, tanned RBC. For antigen controls, sensitized, 
tanned RBC were reacted with dilutions of normal rabbit or normal human sera, rabbit sera 
containing  heterologous  antibody, and with  saline. A standard serum producing positive hemag- 
glutination of a known titer was included with each group of sera tested. 
Hemagglutination Inhibition.--Solutions  of antigens for inhibition were diluted in pI-I 7.2 
buffer containing 1 per cent NRS.  The dilutions of inhibiting antigens (usually a  100-  to 
1000-fold  range) were added in 0.1 ml amounts to 0.4 ml of one or more selected dilutions of 
a serum of known hemagglutination titer. The tubes were mixed and allowed to stand at room 
temperature for 30 minutes. Then 0.05 ml of sensitized RBC was added and the tubes were 
shaken again and refrigerated overnight. Reactions were graded as in hemagglutination. A 
titration of the hemagglutinating system without inhibitor was made concurrently. 
KESO'LI~ 
After it was found in preliminary experiments that certain preparations of A 
carbohydrate  would attach  to  tanned  human  O  erythrocytes  and  produce 
agglutination  in  the  presence  of  specific  antibody,  other  experiments  were 
conducted to determine optimum conditions for the reaction. The conditions 
described under Materials and Methods for concentration of RBC, tannic acid, 
pH, temperature, and time for tavnlng and sensitizing  RBC represent optima. 
Treatment of RBC with tannic acid was essential.  Hemagglutination in the A 
polysaccharide  system  was  much  better  at 4 °  than at  25 °  or 37°C.  Reactions 
could be read  as early as 4  hours but  were maximal  after  16 hours. Time  and 796  ANTIBODY  TO GROUP  A  STREPTOCOCCAL  POLYSACCHARIDE 
temperature had tittle if any effect on the reaction of antibody with inhibiting 
antigen. 
Preparations  of Polysacckaride  Effective  as  Hemagglutinating  Antigens.--A 
survey  of  a  number  of  preparations  of  A  polysaccharide  revealed  marked 
differences in their ability to sensitize tanned RBC for hemagglutination. 
To compare the various forms of polysaccharide, a volume of tanned  0  RBC was mixed 
with an equal volume of polysaccharide of the concentration listed in Table I for sensitization. 
After washing, the sensitized cells were added to serial dilutions of a Group A antistreptococcal 
serum and to two dilutions of a Group B serum. 
TABLE I 
Itemagglutination  Reactions of  Preparations of  A  Polysaccharide 
Sensitizing  antigen 
Preparation 
Connc@~- 
tration 
tag rt~m- 
sose/ml 
Reciprocal of serum dilution 
100  200 
Group  A 
800  1600 ! 3200 J  50 
Group  B 
j 
100 
Formamide  (No. S) ................... 
~. a/bus (No. 10) ..................... 
S. a/bus (No. 14) ..................... 
DFP-S. a/bus (No. 13) ............... 
DFP-S. a/bus (No. 12) ethanol fraction.. 
DFP-S. a/bus (No. 12) ethanol fraction.. 
DFP-S. a/bus (No. 12) acetone fraction.. 
DFP-S.  a/bus (No.  12)  ethanol  frac- 
tion +  trypsin ..................... 
45 
45 
49 
5 
5 
2.6 
47 
130 
3+  3+  2+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
+ 
4+ 
4+ 
4+ 
-!-  -- 
4+ 
4+  - 
3+  +  -- 
_  [ 
i  i 
i  ! 
* Reactions as described in reference 23 with the exception that the more compact reaction 
read as 4- there is read as -  here. 
The  relative  efficacy  of  the  different  preparations  of  A  carbohydrate  as 
hemagglutinating  antigens  was  estimated  from  the  extent  of  agglutination 
produced per microgram of polysaccharide rhamnose employed for sensitization. 
The results are presented in Table I. Sensitization of tanned RBC with forma- 
mide-extracted A carbohydrate could not be accomplished. Of several prepara- 
tions  tested,  only one lot  (No.  10)  of polysaccharide prepared  with  S.  a/bus 
enzyme without DFP sensitized RBC for hemagglutination at relatively high 
antigen  concentrations.  A-carbohydrate  purified  from  DFP-treated  S.  albns 
enzyme lysates produced uniformly good sensitization of RBC at concentrations 
less  than  5/zg of polysaccharide rhamnose per ml.  Mter  fractionation  of the 
0.6  saturated  (NI-I,)2SO4  supernate  of  DFP-S.  albus  enzyme  lysates  with 
ethanol  and  acetone  (6),  hemagglutinating  antigen  was  found  only  in  the 
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Treatment of ethanol-precipitated A polysaccharide with crystalline trypsin 
(10 #g trypsin per ml at pH 8, 37°C for 5 hours; reaction stopped with DFP) 
abolished the ability to sensitize tanned RBC for hemagglutination. Since the 
mucopeptide is the only portion of enzymatically  prepared A carbohydrate that 
can be hydrolyzed by trypsin, it may be inferred from the trypsin effect that 
the attachment of A  polysaccharide to tanned O  erythrocytes is effected by 
way of the mucopeptide. 
Further  fractionation  of  ethanol-precipitated  polysaccharide  by  chroma- 
tography on CM  cellulose has also provided evidence of the dependence of 
sensitization of RBC on the mucopeptide conjugated to A polysaccharide. The 
major portion of ethanol-precipitated A carbohydrate was not adsorbed to CM 
cellulose equilibrated with pH 6.4, F/2 0.01 phosphate buffer and emerged from 
TABLE II 
Specificity of A Polysacckaride Hemaggtutination 
Sensitizing antigen  Recipro~l of ~rum dilution 
Group G 
Preparation 
polysaccharide  DFP-S. 
a/bus-ethanol  ......... 
polysaccl~ride  DFP-S. 
a~bus--ethanol +  A enzyme. 
~-variant  polysaccharide 
DFP-S. a/bus-ethanol. 
Conc~m- 
tration 
Group A  Group B  Group  C 
100  400  800  1500  50  100  50  100 
sose/r,a 
10 
128 
50 
I 
4+  4+  3+]  + 
+ 
5O  100 
d: 
the  column  with  the  initial  solvent.  This  fraction contained relatively less 
sensitizing antigen than a small portion of the A polysacchafide eluted from the 
column between ionic strength 0.05 and 0.1. The latter fraction contained from 
2.5 to 3 times as much mucopeptide  as the major unadsorbed polysaccharide 
fraction. 
Specificity  of A  Polysavckaride Hemagglutination.--Reactions  demonstrating 
the specificity of A polysaccharide hemagglutination are presented in Table H. 
Agglutination of tanned RBC sensitized with A  polysaccharide was demon- 
strable with Group A antistreptococcal rabbit sera but not with Groups B, C, 
or G antisera. 
Sensitization of human O RBC with the ethanol-precipitated fraction of A carbohydrate 
was performed as detailed in the Materials and Methods section. Similar conditions  were 
employed  in treating tanned O RBC with several  preparations  and concentrations  of A-variant 
polysaccharide.  To sensitize  RBC with A ermyme-trcated  A carbohydrate,  several milligrams 798  ANTIBODY TO GROUP A  STREPTOCOCCAL POL¥SACCHARIDE 
of ethanol polysaccharide  were hydrolyzed with A enzyme. The hydrolysate was then diluted, 
and a number of concentrations were reacted with tanned O RBC in the usual manner. 
Tanned RBC sensitized with A polysaccharide that had been treated with A 
enzyme  which  hydrolyzes  the  immunologically  specific  A  determinant  (21) 
were  not  agglutinated  by  Group  A  or  other  antistreptococcal  rabbit  sera. 
Attempts  to  sensitize  tanned  RBC  with  A-variant polysaccharide produced 
variable results.  Clear-cut hemagglutination patterns were not obtained,  and 
when agglutination did occur it was of low titer. Reactions with A  as well as 
A-variant sera were usual; often the titer with A  antiserum was greater than 
that of the A-variant serum. It is likely that the positive reactions were due to 
TABLE III 
Inhibition of A PoIysaccharide Hemagglutination 
Inhibitor 
A polysaccharide (formamide)  ................ 
A polysaccharide (S. a/bus) .................. 
A polysaccharide (DFP-S. a/bus-ethanol) ...... 
A polysaccharide +  trypsin .................. 
A polysaccharide +  A enzyme .............. 
A-variant polysaccharide ................... 
/3-phenyl-N-acetylglucosaminide*, ~/ .......... 
Hemagglutination  in presence of inhibitor, 
concentration  of inhibttor in ~g. of rhasmaos¢ 
s_L_°  1._2_° 
--  m 
+  2+ 
2+ 
2+  2+ 
0.5  0.05 
±  + 
2+ 
3+ 
2+ 
0.005 1 
2+ 
+  3+ 
-4-  3+ 
--  2+ 
2+  2+ 
3+  3+ 
3+ 
3+ 
3+ 
3+ 
3+ 
3+ 
3+ 
* Concentration expressed in #g of phenylacetylglucosaminide. 
:~ Generously supplied by Dr. M. McCarty. 
small amounts  of A  polysaccharide present in  the  preparations  of A-variant 
carbohydrate. 
Hemaggbutination  Inhibition  Reactions.--Inhibition  of  A  polysaceharide 
hemagglutination provided further evidence of the specificity of this serological 
reaction. Concentrations of A carbohydrate as small as 0.05 gg of polysaccharide 
rhamnose produced  inhibition  of agglutination  of A  carbohydrate-sensitized 
tanned  RBC.  All  preparations  of  A  polysaccharide  had  approximately the 
same inhibition effect as illustrated in Table III. A-variant polysaccharide had 
no inhibiting effect. The evidence that trypsin-treated A polysaccharide was a 
good inhibitor  provided further indication  that  the  action  of trypsin on  the 
RBC-sensifizing  property  of  the  ethanol  fraction  of  A  polysaccharide  pre- 
viously described  (Table I) was not on the immunologic determinant but on 
the site of attachment of the polysaccharide molecules to the tanned red cell. 
Exposure  of  A  carbohydrate  to  A  enzyme,  which  removes  the  /%N-acetyl- 
glucosamine  serologic  determinant  (21),  destroyed  its  hemagglutination- WILLARD  C.  SCHMIDT  AND  DOROTHY  J.  MOORE  799 
inhibiting ability. McCarty, in establishing the identity of the A polysaccharide 
determinant  as  /3-linked  N-acetylglucosamine,  demonstrated  significant 
inhibition of the precipitin reaction of A polysaccharide and A antibody by N- 
acetylglucosamine  and  phenyl-/3-N-acetylglucosaminide  (25).  Experiments 
employing these reagents in concentrations of 0.02 to 2000 #g per ml as inhibitors 
of A  polysaccharide hemagglutination  were unsuccessful.  An  example  of the 
inability  of  several  concentrations  of  /3-phenyl-N-acetylglucosaminide  to 
inhibit A polysaccharide hemagglutination is illustrated in Table III. 
ttemagglutination  and  Hemagglutination  Inhibition  with  Human  Sera.--To 
determine the  specificity of the  A  polysaccharide hemagglutination  reaction 
with  human  antisera,  sera  from  two  patients  with  Group  A  streptococcal 
TABLE IV 
A  Carbohydrate  Hemagglutination and Hemagglutination Inhibition with Human Serum  Dra 
Sensitizing antigen 
A polysaccharide  DFP-S. albus-EtOH ..... 
A polysaccharide DFP-S. albus-EtOH  + 
A enzyme  ............................ 
Reciprocal of serum dilution 
200  400  800  1600  3200 
-Z-+ 
Inhibiting antigen 
A polysaccharide  DFP-S. albus-EtOH ..... 
A polysaccharide DFP-S. albus-EtOH  "4- 
A enzyme  ............................ 
Concentration  of inhibitor in #g rhamnose/ml 
5.0  2.5  1.0  0.5  0.05  0 
4+ 
4+  P 4+1  4+r  I  4+ 
sepsis,  known  to  contain  precipitating  antibody  to  A  carbohydrate,  were 
compared with  Group A  rabbit  antisera.  Serum from one of these patients, 
Sch.,  was  kindly  provided  by  Dr.  A.  T.  Wilson  who  previously  described 
capillary precipitation and immunoelectrophoretic reactions of this serum with 
purified A carbohydrate (9). The second patient, Dra., was one of several with 
group A streptococcal sepsis,  observed and treated at Cleveland Metropolitan 
General  Hospital,  who  were  found  to  have  A  carbohydrate  precipitating 
antibody  in  their  sera.  Hemagglutination  and  hemagglutination  inhibition 
reactions of sera from Sch. and Dra. with preparations of A polysaccharide and 
enzyme-treated A polysaccharide were qualitatively identical with the reactions 
of  these  materials  with  antistreptococcal  rabbit  sera  described  above  and 
illustrated in Tables I to III. Experiments illustrating reactions of the ethanol- 
precipitated fraction of A  carbohydrate,  before and  after  treatment  with  A 
enzyme, as sensitizing and inhibiting antigen with Dra. serum are presented in 800  ANTIBODY  TO  GROUP  A  STREPTOCOCCAL  POLYSACCHARIDE 
Table  IV and in  Fig.  1.  This  serum agglutinated A  polysaccharide-sensitized, 
tanned  RBC  to a  dilution of  1/3200.  No hemagglutination was obtained with 
the  same  antigen  after  enzymatic removal of  the  specific immunologic deter- 
minant  with  A  enzyme.  A-carbohydrate  inhibited  the  reaction  of  A  poly- 
saccharide-sensitized  RBC  with  Dra.  serum,  and  loss  of  inhibitory  activity 
accompanied loss of the A polysaccharide determinant. 
Fro. 1. A carbohydrate antibody in human convalescent  serum demonstrated by hemag- 
glutination and  hemagglutination  inhibition with  A polysaccharide  and  A polysaccharide 
treated with A enzyme. 
Row 1.  Hemagglutination: tanned cells sensitized with A carbohydrate; Dra. serum dilu- 
tions, left to right: 1/200 to 1/3200, group B rabbit 1/50, NRS. Row. 2. Cells sensitized with A 
carbohydrate treated with A enzyme;  same  serum  dilutions,  no  hemagglutination.  Row  4. 
Hemagglutination inhibition by A polysaccharide:  concentration  of inhibitor in ~g rhamnose, 
left to right, 0.5, 0.05, 0.005. Row 3. Abolition of A polysaccharide inhibition; same concentra- 
tion of A polysaccharide inhibitor used after treatment with A enzyme. 
After demonstration of the specificity of A  polysaccharide hemagglutination 
with human  sera, serum specimens from patients with various forms of strep- 
tococcal  infection,  non-suppurative  streptococcal  sequelae,  and  from  normal 
children and adults were tested to obtain information about the nature of the A 
carbohydrate antibody response in man.  Most of the sera examined contained 
A  carbohydrate antibody, and considerable variation in the titers of this anti- 
body was evident. Quantitative comparisons of sera from various categories of 
streptococcal disease were made after experiments were performed to determine 
the accuracy of the titration of A polysaccharide antibody by hemagglutination. 
Repeated titrations of several human  and rabbit sera were made; titrations of WlLLARD C.  S~  AND DOROTHY J.  MOORE  801 
the same serum did not usually result in a  variation of more than one dilution 
increment in  the end point (reaction of 1+  or more). The hemagglutination 
titers  of A  antibody in  a  series of rabbit sera were  roughly proportional to 
mounts  of A  antibody in these sera determined by quantitative precipitation. 
Therefore,  estimation  of A  polysaccharide antibody by hemagglutination  is 
TABLE V 
A  Polysaccharide Hemagglutinating Antibody  in  Human  Sera 
Serum 
Dra. 1". :~  .............. 
Dra. 25 ................ 
Dra. 35 ................ 
Sch. 2~ ................ 
Car. § .................. 
Day. § ................. 
Fra.§ .................. 
Sev. 1[l ................ 
Sev. 2§ ................ 
Ruc.¶ .................. 
Bar.¶ .................. 
Jon.¶ .................. 
Cor.lj  .................. 
Cru.** ................. 
Har.** ................. 
Gur.:~ ................. 
Gin.:~$  ................. 
Nid.t~ ................. 
Reciprocal of serum dilution 
20 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
3+ 
3+ 
3+ 
4+ 
50  100 
3+  3+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  2+ 
4+  2+ 
3+  + 
4+  2+ 
3+  3+ 
3+  2+ 
4+  4+ 
4+  4+ 
3+  -- 
2+  -- 
3+  -- 
4+  4+ 
!00 
3q 
4q 
4q 
~q 
+ 
+ 
-4- 
2q 
2q 
4q 
4q 
+ 
4C0  800 
2-+  ++ 
4-+ 
4-+  4+ 
3-+  3+ 
+  -4- 
+  + 
4q  + 
+  -- 
160  32OO 
4- 
2-  2+ 
+  .4- 
m 
m 
4- 
640O 
4- 
* Numbers indicate the sequence of specimens obtained from the same patient. 
:~ Streptococcal sepsis. 
§ Convalescent untreated streptococcal  infection. 
[[ Acute phase  streptococcal infection. 
¶ Acute rheumatic fever. 
** "Normal" child. 
~  "Normal" adult. 
probably comparable to fitrations of other streptococcal antibodies which are 
similarly subject to the limitations of the serum dilution technique. 
A  typical titration of A carbohydrate antibody in sera from normal children, 
adults,  and  patients  during  several  phases  of  streptococcal  infection  and 
rheumatic fever is presented in Table V.  Serum  Dra.  I  was  obtained during 
the acute phase of streptococcal sepsis; serum Dra. 2 drawn 3 weeks later had 
the same titer of A  antibody: 800. A  rise in antibody to 3200 was detected in a 
third  serum  obtained  8  weeks  after  the  second.  Serum  Sch.  was  from  the 802  ANTIBODY  TO  GROUP  A  STREPTOCOCCAL  POLYSACCHARIDE 
patient with sepsis studied by Wilson. Sera from Car., Dav., Fra., and Sev. (2) 
were collected during the convalescent stage of untreated streptococcal pharyn- 
gitis, 5 to 7 weeks after the onset of symptoms. In the second serum from Sev., 
which was obtained 5 weeks after the first specimen, a rise in the A antibody 
titer from 100 to 400 was found. A-polysaccharide hemagglufinating antibody 
titers of 200 to 800 units were found in the three serum specimens from patients 
with acute rheumatic fever. Sixty to 70 per cent of normal children and adults 
were found to have demonstrable A carbohydrate antibody in their sera; the 
titers were usually less than 100. Children were less likely to have detectable A 
antibody, depending upon age and epidemiological circumstances. In a  small 
collection of sera from young children with viral disease, 75 per cent did not 
contain A-hemagglutinating antibody, whereas 8 of 9 children in an orphanage 
population  where  many streptococcal carriers  were present  had  measurable 
TABLE VI 
A Polys~charideHemagglutinatingAn~body 
Category 
Normal child  ............................... 
Normal adult ............................... 
Streptococcal infection  ....................... 
Rheumatic fever or nephritis  ................. 
Streptococcal sepsis  .......................... 
Reciprocal of serurn dilution 
Range 
0-800 
0-400 
50-800 
50-1600 
800-3200 
Median 
50 
50 
200 
400 
1600 
antibody titers. In several sera from infants collected during the acute phase of 
streptococcal infection, A  carbohydrate antibody was  not present nor did it 
appear in specimens collected 2 to 3 weeks later. In adults who had A antibody 
initially, a  rise in antibody did not occur until 4  weeks or more after strep- 
tococcal infection. A  antibody fiters decreased minimally or persisted  for at 
least several months. 
If the A polysaccharide antibody titers of normal persons and patients with 
localized streptococcal infections,  sepsis,  rheumatic  fever,  and  glomerulone- 
phritis are collectively  examined, a variation in the intensity of antibody response 
similar  to  that  of  several  other  streptococcal antibodies  (1,  2)  is  found.  A 
summary of the antibody determinations of 86 sera showing the range and the 
median titers in these categories, is presented in Table VI. Normal persons were 
found to have a median fiter of A hemagglufinating antibody of 50.  Patients 
convalescent from Group A  streptococcal infections demonstrated a  fourfold 
greater median value. The median response in patients with rheumatic fever 
and glomerulonephritis is somewhat higher than that following uncomplicated WILLARD C.  SCrr~mT  AND  DOROTHY J.  MOORE  803 
infection.  Although few patients with sepsis were studied, the greatest antibody 
response was evident in this group experiencing  intensive antigenic stimulus. 
DISCUSSION 
Previous  experience  with  the  measurement  of  streptococcal antibodies  in 
man has demonstrated that highly sensitive techniques are necessary to detect 
the small  amounts of a specific antibody formed after natural infection (26). 
In this investigation, hemagglutinafion was selected as a method for measuring 
A  polysaccharide  antibody  because  of  its  sensitivity  (23)  and  because  the 
specificity of the hemagghitination reaction could be critically tested with the 
specific  /%acetylglucosaminidase  and  the  /~-acetylglucosaminide  inhibitor 
employed by McCarty in the lucid demonstration of the chemical nature of the 
A carbohydrate determinant (21, 25). 
Recent  evidence  that  mucopepfide  components  of  the  cell  wall  remain 
conjugated to enzymicaUy released A polysaccharide (6, 27) provided another 
reason  for  attempting  hemagglutination  with  the  A  carbohydrate;  certain 
mucopeptide  fragments  might  contain  reactive  groups  more  likely  to  bind 
polysaccharide  to  tannic  acid-treated  erythrocytes.  Substantiation  for  this 
hypothesis was found in the observation that only a particular, mucopeptide- 
containing  fraction  of A polysaccharide solubilized  by DFP-treated S.  a/bus 
enzyme, namely the ethanol precipitate and chromatographic fractions of this 
precipitate, attached to RBC; whereas the acetone precipitate of DFP-treated 
S. a/bus lysates, S. a/bus lysates (with one exception), and formamide-extracted 
A  carbohydrate  would not  sensitize  RBC.  It  was  also  found  that  trypsin 
destroyed the  capacity of the ethanol  A  carbohydrate fraction  to attach  to 
tanned RBC without altering its activity in hemagglutination inhibition. 
A  series  of  experiments  was  presented  to  identify  the  hemagglutinating 
reactant in human sera as A carbohydrate antibody. First, it was demonstrated 
that  A polysaccharide-sensitized RBC reacted with  Group A rabbit antisera 
but not with antisera of Groups B, C, and G. This reaction was inhibited by A 
carbohydrate and abolished by treatment of the RBC-sensitizing antigen with 
A enzyme which removes the immunologically specific A carbohydrate deter- 
minant. Then, it was shown that A polysaccharide inhibited hemagglutination 
of the same antigen-coated RBC by human sera known to contain A carbo- 
hydrate antibody. This reaction was eliminated by treatment of the inhibiting 
antigen with A enzyme and by A enzyme hydrolysis of the sensitizing  antigen 
before it was reacted with tanned RBC. 
No ready explanation  is forthcoming to account for the failure to demon- 
strate inhibition of A polysaccharide hemagglutination by N-acetylglucosamine 
or phenyl-N-acetylglucosaminide which McCarty found effective in producing 
partial  inhibition  in  the  A  carbohydrate-A  antibody  precipitating  system 
(25).  It  has  been suggested  that  incomplete  inhibition  in  this  precipitating 804  ANTIBODY  TO GROUP  A  STREPTOCOCCAL  POLYSACCHARIDE 
system and lack of cross-reactivity between A polysaccharide and azophenyl-N- 
acetylglucosaminide antisera (25) occur because A antibody-combining sites are 
mainly  complementary  to  A  carbohydrate  oligosaccharides  with  terminal 
fl-N-acetylglucosamirfide  units (28). It is possible that the determinants of the 
A carbohydrate fixed to tanned RBC are by chance those that react only with 
A  antibody  with  combining  sites  complementary  to  oligosaccharides  which 
monomeric  inhibitors  will  not  satisfy.  It  is  also  possible that  inhibition  of 
hemagglutination  was not demonstrated  because the glucosaminide  inhibitor 
was employed in too low a concentration. 
The  studies of A  polysaccharide antibody in  human  sera  that  have  been 
conducted do not as yet permit accurate description of the natural history of 
the A  carbohydrate antibody response  following  streptococcal infection,  but 
several tentative features emerge. Most persons except infants and some young 
children  have circulating  A carbohydrate antibody. The A antibody response 
appears  to  be relatively slow  following  streptococcal infection  and  is  more 
persistent,  resembling  M  antibody  in  contrast  to  streptolysin  O  antibody 
(2, 26, 29). Patients with the non-suppurative sequelae seem to have a somewhat 
greater  A  antibody  response  than  those  experiencing  uncomplicated  strep- 
tococcal infection. 
SUMMARY 
A  hemagglutination  method  employing  tanned  human  O  erythrocytes 
sensitized  with  purified  Group A  streptococcal polysaccharide has  been de- 
veloped to measure A polysaccharide antibody in antistreptococcal rabbit and 
human sera. 
The reaction of sensitized  RBC with known Group A streptococcal rabbit 
antisera, inhibition of hemagglutination  with A polysaccharide, and abolition 
of  hemagglutinafion  and  hemagglutination-inhibition  by  exposure  of  poly- 
saccharide  antigen  to  A  enzyme,  which  destroys  the  specific  immunologic 
determinant of A carbohydrate, were utilized to demonstrate the specificity of 
this hemagglutinating system. 
The  results  of  A  polysaccharide  antibody  determinations  on  sera  from 
normal  persons,  patients  convalescent  from  streptococcal  infection,  and 
patients with non-suppurative streptococcal sequelae are presented. 
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